Johnson & Johnson pauses coronavirus vaccine trial following ‘unexplained illness’ in participant

Johnson & Johnson pauses coronavirus vaccine trial following ‘unexplained illness’ in participant

Fox News Flash top headlines for October 13 Fox News Flash top headlines are here. Check out what&#8...
read more
Final Results of National Institute of Allergy and Infectious Diseases’ ACTT-1 Trial Published in New England Journal of Medicine Expand Clinical Benefits of Veklury® (remdesivir) for the Treatment of COVID-19

Final Results of National Institute of Allergy and Infectious Diseases’ ACTT-1 Trial Published in New England Journal of Medicine Expand Clinical Benefits of Veklury® (remdesivir) for the Treatment of COVID-19

FOSTER CITY, Calif.–(BUSINESS WIRE)–Oc...
read more
Moderna COVID vaccine trial didn't enroll enough minority volunteers

Moderna COVID vaccine trial didn't enroll enough minority volunteers

Moderna’s coronavirus vaccine trial results ...
read more
Anti-Influenza Drug Avigan® Tablet Meets Primary Endpoint in Phase III Clinical Trial in Japan for COVID-19 Patients

Anti-Influenza Drug Avigan® Tablet Meets Primary Endpoint in Phase III Clinical Trial in Japan for COVID-19 Patients

TOKYO — September 23, 2020 FUJIFILM Toyama C...
read more
AstraZeneca releases COVID-19 vaccine trial plans

AstraZeneca releases COVID-19 vaccine trial plans

(HealthDay)—AstraZeneca is the latest drug compa...
read more
Details emerge on unexplained illness in AstraZeneca COVID vaccine trial

Details emerge on unexplained illness in AstraZeneca COVID vaccine trial

New details surfaced on Thursday on an unexplained...
read more
Why halting the COVID-19 vaccine trial is part of the process

Why halting the COVID-19 vaccine trial is part of the process

This week the University of Oxford and Astra Zenec...
read more
Why AstraZeneca just paused its coronavirus vaccine trial

Why AstraZeneca just paused its coronavirus vaccine trial

Clinical trials for the COVID-19 vaccine developed...
read more
New drug shown to improve bone growth in children with achondroplasia in global phase III trial

New drug shown to improve bone growth in children with achondroplasia in global phase III trial

A phase three global clinical trial led by the Mur...
read more
Clinical trial focuses on reducing overactive immune response in COVID-19

Clinical trial focuses on reducing overactive immune response in COVID-19

Researchers at Washington University School of Med...
read more